Resistance to recombinant human erythropoietin therapy in haemodialysis patients: Focus on inflammatory cytokines, leukocyte activation, iron status and erythrocyte damage

Anaemia is a common complication in haemodialysis patients. This condition is associated to a decreased bone marrow production of erythrocytes, mainly due to the inability of the failing kidneys to secrete erythropoietin (EPO). The introduction of recombinant human EPO (rhEPO) therapy led to a signi...

ver descrição completa

Detalhes bibliográficos
Autor principal: Costa, Elísio (author)
Outros Autores: Belo, Luís (author), Quintanilha, Alexandre (author), Santos-Silva, Alice (author)
Formato: article
Idioma:eng
Publicado em: 2010
Assuntos:
Haemodialysis
Resitance to rhEPO therapy
Erythropoietin
Inflammation
Leukocyte activation
Iron status
Erythrocyte damage
Texto completo:http://hdl.handle.net/10400.14/3025
País:Portugal
Oai:oai:repositorio.ucp.pt:10400.14/3025

Texto Completo

http://hdl.handle.net/10400.14/3025

Registos relacionados